Pulmonary Emphysema and Coronary Artery Calcifications at Baseline LDCT and Long-term Mortality in Smokers and Former Smokers of the ITALUNG Screening Trial

Overview

Journal Eur Radiol

Specialty Radiology

Date 2023 Mar 1

PMID 36854875

Authors

Mario Mascalchi

Chiara Romei

Chiara Marzi

Stefano Diciotti

Giulia Picozzi

Francesco Pistelli

Marco Zappa

Eugenio Paci

Francesca Carozzi

Giuseppe Gorini

Fabio Falaschi

Anna Lisa Deliperi

Gianna Camiciottoli

Laura Carrozzi

Donella Puliti

Affiliations

Soon will be listed here.

Abstract

Objectives: Cardiovascular disease (CVD), lung cancer (LC), and respiratory diseases are main causes of death in smokers and former smokers undergoing low-dose computed tomography (LDCT) for LC screening. We assessed whether quantification of pulmonary emphysematous changes at baseline LDCT has a predictive value concerning long-term mortality.

Methods: In this longitudinal study, we assessed pulmonary emphysematous changes with densitometry (volume corrected relative area below - 950 Hounsfield units) and coronary artery calcifications (CAC) with a 0-3 visual scale in baseline LDCT of 524 participants in the ITALUNG trial and analyzed their association with mortality after 13.6 years of follow-up using conventional statistics and a machine learning approach.

Results: Pulmonary emphysematous changes were present in 32.3% of subjects and were mild (6% ≤ RA950 ≤ 9%) in 14.9% and moderate-severe (RA950 > 9%) in 17.4%. CAC were present in 67% of subjects (mild in 34.7%, moderate-severe in 32.2%). In the follow-up, 81 (15.4%) subjects died (20 of LC, 28 of other cancers, 15 of CVD, 4 of respiratory disease, and 14 of other conditions). After adjusting for age, sex, smoking history, and CAC, moderate-severe emphysema was significantly associated with overall (OR 2.22; 95CI 1.34-3.70) and CVD (OR 3.66; 95CI 1.21-11.04) mortality. Machine learning showed that RA950 was the best single feature predictive of overall and CVD mortality.

Conclusions: Moderate-severe pulmonary emphysematous changes are an independent predictor of long-term overall and CVD mortality in subjects participating in LC screening and should be incorporated in the post-test calculation of the individual mortality risk profile.

Key Points: • Densitometry allows quantification of pulmonary emphysematous changes in low-dose CT examinations for lung cancer screening. • Emphysematous lung density changes are an independent predictor of long-term overall and cardio-vascular disease mortality in smokers and former smokers undergoing screening. • Emphysematous changes quantification should be included in the post-test calculation of the individual mortality risk profile.

Citing Articles

Is Type and Grade of Emphysema Important for Bone Mineral Density and Aortic Calcifications?.

Vukovic D, Budimir Mrsic D, Ordulj I, Saric F, Tandara M, Jerkovic K J Clin Med. 2024; 13(13).

PMID: 38999515 PMC: 11242253. DOI: 10.3390/jcm13133947.

How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?.

Hardavella G, Frille A, Chalela R, Sreter K, Petersen R, Novoa N Eur Respir Rev. 2024; 33(172).

PMID: 38925794 PMC: 11216686. DOI: 10.1183/16000617.0232-2023.

Cardiac troponin I as predictor for cardiac and other mortality in the German randomized lung cancer screening trial (LUSI).

Cortes-Ibanez F, Johnson T, Mascalchi M, Katzke V, Delorme S, Kaaks R Sci Rep. 2024; 14(1):7197.

PMID: 38531926 PMC: 10965973. DOI: 10.1038/s41598-024-57889-z.

The association of chest computed tomography-defined visual emphysema and prognosis in patients with nonsmall cell lung cancer.

Zhang Y, Yi J, Sun D, Su Y, Zuo Y, Zhu M ERJ Open Res. 2023; 9(6).

PMID: 38020560 PMC: 10658642. DOI: 10.1183/23120541.00195-2023.

Impact of smoking in patients with suspected coronary artery disease in the randomised DISCHARGE trial.

Mancone M, Mezquita A, Birtolo L, Maurovich-Horvat P, Kofoed K, Benedek T Eur Radiol. 2023; 34(6):4127-4141.

PMID: 37991508 DOI: 10.1007/s00330-023-10355-2.

References

Shaker S, Dirksen A, Lo P, Skovgaard L, De Bruijne M, Pedersen J . Factors influencing the decline in lung density in a Danish lung cancer screening cohort. Eur Respir J. 2012; 40(5):1142-8. DOI: 10.1183/09031936.00207911. View

Pegna A, Picozzi G, Falaschi F, Carrozzi L, Falchini M, Carozzi F . Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol. 2013; 8(7):866-75. DOI: 10.1097/JTO.0b013e31828f68d6. View

Ten Haaf K, van der Aalst C, de Koning H, Kaaks R, Tammemagi M . Personalising lung cancer screening: An overview of risk-stratification opportunities and challenges. Int J Cancer. 2021; 149(2):250-263. PMC: 8251929. DOI: 10.1002/ijc.33578. View

Krist A, Davidson K, Mangione C, Barry M, Cabana M, Caughey A . Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021; 325(10):962-970. DOI: 10.1001/jama.2021.1117. View

Schreuder A, Jacobs C, Lessmann N, Broeders M, Silva M, Isgum I . Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening. Eur Respir J. 2021; 58(3). DOI: 10.1183/13993003.03386-2020. View

Sverzellati N, Cademartiri F, Bravi F, Martini C, Gira F, Maffei E . Relationship and prognostic value of modified coronary artery calcium score, FEV1, and emphysema in lung cancer screening population: the MILD trial. Radiology. 2011; 262(2):460-7. DOI: 10.1148/radiol.11110364. View

Janssens J, Herrmann F, MacGee W, Michel J . Cause of death in older patients with anatomo-pathological evidence of chronic bronchitis or emphysema: a case-control study based on autopsy findings. J Am Geriatr Soc. 2001; 49(5):571-6. DOI: 10.1046/j.1532-5415.2001.49116.x. View

Cavigli E, Camiciottoli G, Diciotti S, Orlandi I, Spinelli C, Meoni E . Whole-lung densitometry versus visual assessment of emphysema. Eur Radiol. 2009; 19(7):1686-92. DOI: 10.1007/s00330-009-1320-y. View

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

10.

Mascalchi M, Camiciottoli G, Diciotti S . Lung densitometry: why, how and when. J Thorac Dis. 2017; 9(9):3319-3345. PMC: 5708390. DOI: 10.21037/jtd.2017.08.17. View

11.

Sorensen L, Nielsen M, Petersen J, Pedersen J, Dirksen A, De Bruijne M . Chronic Obstructive Pulmonary Disease Quantification Using CT Texture Analysis and Densitometry: Results From the Danish Lung Cancer Screening Trial. AJR Am J Roentgenol. 2020; 214(6):1269-1279. DOI: 10.2214/AJR.19.22300. View

12.

Williams M, Murchison J, Edwards L, Agusti A, Bakke P, Calverley P . Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 2014; 69(8):718-23. DOI: 10.1136/thoraxjnl-2012-203151. View

13.

Kaaks R, Christodoulou E, Motsch E, Katzke V, Wielputz M, Kauczor H . Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality. Transl Lung Cancer Res. 2022; 11(9):1896-1911. PMC: 9554689. DOI: 10.21037/tlcr-22-63. View

14.

Camiciottoli G, Cavigli E, Grassi L, Diciotti S, Orlandi I, Zappa M . Prevalence and correlates of pulmonary emphysema in smokers and former smokers. A densitometric study of participants in the ITALUNG trial. Eur Radiol. 2008; 19(1):58-66. DOI: 10.1007/s00330-008-1131-6. View

15.

Chiles C, Duan F, Gladish G, Ravenel J, Baginski S, Snyder B . Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. Radiology. 2015; 276(1):82-90. PMC: 5137795. DOI: 10.1148/radiol.15142062. View

16.

Kirby M, Hatt C, Obuchowski N, Humphries S, Sieren J, Lynch D . Inter- and intra-software reproducibility of computed tomography lung density measurements. Med Phys. 2020; 47(7):2962-2969. PMC: 7944589. DOI: 10.1002/mp.14130. View

17.

Wille M, Thomsen L, Dirksen A, Petersen J, Holst Pedersen J, Shaker S . Emphysema progression is visually detectable in low-dose CT in continuous but not in former smokers. Eur Radiol. 2014; 24(11):2692-9. DOI: 10.1007/s00330-014-3294-7. View

18.

Xie X, Dijkstra A, Vonk J, Oudkerk M, Vliegenthart R, Groen H . Chronic respiratory symptoms associated with airway wall thickening measured by thin-slice low-dose CT. AJR Am J Roentgenol. 2014; 203(4):W383-90. DOI: 10.2214/AJR.13.11536. View

19.

Morgan A, Zakeri R, Quint J . Defining the relationship between COPD and CVD: what are the implications for clinical practice?. Ther Adv Respir Dis. 2018; 12:1753465817750524. PMC: 5937157. DOI: 10.1177/1753465817750524. View

20.

Mascalchi M, Mazzoni L, Falchini M, Belli G, Picozzi G, Merlini V . Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT. Br J Radiol. 2011; 85(1016):1134-9. PMC: 3587091. DOI: 10.1259/bjr/20711289. View